Penn CIGHT is part of the National Human Genome Research Institute (NHGRI)s announcement earlier this month about the establishment of two new ELSI centers to address the most critical ethical, legal and social questions relating to genetics faced by clinicians, researchers, and patients. The other new center will be at the University of North Carolina-Chapel Hill.
Examining the emerging ethical, legal and social implications of genomic research is central to our goal of safely and effectively moving discoveries into the clinic, said NHGRI Director Francis S. Collins, MD, PhD. These centers will work to identify and address the most pressing issues being confronted by individuals, families, and communities as a result of genetic and genomic research.
The work of the new Penn center will be conducted by a team of experts representing a broad range of disciplines, such as medicine, bioethics, law, behavioral and social sciences, clinical research, public policy, economics, and genetic and genomic research. The interdisciplinary nature of this team will allow the center to develop innovative research approaches focused on specific sets of issues that relate to the numerous applications and uses of genomic research, technologies, and information. The Center will also train investigators in methods to evaluate the implications and utility of future genetic technologies and discoveries.
The new Penn center will give us the structure and resources needed to respond quickly to the clinical integration of new genetic discoveries, say Bernhardt, a genetic counselor
'/>"/>
| Contact: Karen Kreeger karen.kreeger@uphs.upenn.edu 215-349-5658 University of Pennsylvania School of Medicine Source:Eurekalert |